Decades have passed since deuterated drugs were first explored and reached late-stage clinical evaluation. Deuterium-modified or deuterated compounds retain the potency and selectivity of their hydrogen analogs. In some cases, deuterium isotope effects can significantly alter drug metabolism, which may have a positive impact on safety, tolerability, or efficacy properties. The idea of deuterium generally includes two kinds, one is to design new compounds from scratch, and the other is to start from existing drugs and complete deuterium substitutions at specific positions without modifying the drug stent in other ways. Our DCL™ technology platform is able to employ both modes to generate new deuterated chemical entities.
The success of deuterated drug candidates is the result of a combination of factors. What we can do is to provide and create a project environment full of favorable factors for our clients. Our services include but are not limited to:
Fig.1 Preclinical drug development stages.
BOC Sciences has a comprehensive business scope, providing end-to-end solutions for the discovery, development and production of deuterated drugs. We have rich project experience and excellent technology platform, which greatly enhances customer stickiness. As one of the industry leaders, our orders and production capacity continue to increase, which keeps our performance at a high growth rate. This shows that for a long time in the future, we will maintain a strong momentum of development.
Our one-to-one project leader system will provide you with professional and efficient services, effectively shortening the development cycle.
BOC Sciences has always regarded intellectual property as the most valuable asset of the company and its customers. We have signed non-disclosure agreements with customers and employees before the project starts, and provide synthetic route design and synthesis services in strict accordance with the terms of the non-disclosure agreement, striving to provide customers with target compounds in the shortest time possible.
BOC Sciences' DCL™ platform provides a deuterium strategy for both high-end custom markets and basic product needs. Our main business areas cover drug development, omics analysis, scientific research testing, and other markets, and strive to promote the development of biomedicine and scientific research.